Table of Content

Executive Summary
Scope of Study

1. Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market: Market Outlook
1.1 Industry Outlook
1.1.1 Market Overview and Ecosystem
1.1.2 Key Trends
1.1.3 Epidemiological Analysis of Acute Lymphoblastic Leukemia
1.1.3.1 By Region
1.1.4 Clinical Trials
1.1.4.1 By Phase
1.1.4.2 By Sponsor Type
1.1.5 Regulatory Landscape / Compliance
1.1.5.1 Legal Requirement and Framework in the U.S.
1.1.5.2 Legal Requirement and Framework in the E.U.
1.1.5.3 Legal Requirement and Framework in Japan
1.1.5.4 Legal Requirement and Framework in Rest-of-the-World
1.2 Market Dynamics
1.2.1 Impact Analysis
1.2.2 Market Drivers
1.2.3 Market Restraints
1.2.4 Market Opportunities

2. Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, By Source Type, $Million, 2023-2035
2.1 Autologous
2.2 Allogeneic

3. Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, By Target Type, $Million, 2023-2035
3.1 CD-19
3.2 CD-22
3.3 Others

4. Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, By Region, $Million, 2023-2035
4.1 North America
4.1.1 Key Findings
4.1.2 Market Dynamics
4.1.3 Market Sizing and Forecast
4.1.3.1 U.S. CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Country)
4.1.3.1.1 U.S.
4.2 Europe
4.2.1 Key Findings
4.2.2 Market Dynamics
4.2.3 Market Sizing and Forecast
4.2.3.1 Europe CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Country)
4.2.3.2 U.K.
4.2.3.3 Germany
4.2.3.4 France
4.2.3.5 Italy
4.3 Asia-Pacific
4.3.1 Key Findings
4.3.2 Market Dynamics
4.3.3 Market Sizing and Forecast
4.3.3.1 Asia-Pacific CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Country)
4.3.3.2 China
4.3.3.3 Japan

5. Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market - Competitive Benchmarking and Company Profiles
5.1 Competitive Landscape
5.1.1 Key Strategies and Developments by Company
5.1.1.1 Funding Activities
5.1.1.2 Mergers and Acquisitions
5.1.1.3 Regulatory Approvals
5.1.1.4 Partnerships, Collaborations and Business Expansions
5.1.2 Key Developments Analysis
5.2 Company Profiles
5.2.1 Novartis AG
5.2.1.1 Company Overview
5.2.1.2 Product Portfolio
5.2.1.3 Target Customers/End Users
5.2.1.4 Analyst View
5.2.2 Autolus Therapeutics
5.2.2.1 Company Overview
5.2.2.2 Product Portfolio
5.2.2.3 Target Customers/End Users
5.2.2.4 Analyst View
5.2.3 Gilead Sciences
5.2.3.1 Company Overview
5.2.3.2 Product Portfolio
5.2.3.3 Target Customers/End Users
5.2.3.4 Analyst View
5.2.4 OneChain Immunotherapeutics
5.2.4.1 Company Overview
5.2.4.2 Product Portfolio
5.2.4.3 Target Customers/End Users
5.2.4.4 Analyst View
5.2.5 Cellectis S.A.
5.2.5.1 Company Overview
5.2.5.2 Product Portfolio
5.2.5.3 Target Customers/End Users
5.2.5.4 Analyst View
5.2.6 Wugen, Inc.
5.2.6.1 Company Overview
5.2.6.2 Product Portfolio
5.2.6.3 Target Customers/End Users
5.2.6.4 Analyst View
5.2.7 Bioheng Therapeutics
5.2.7.1 Company Overview
5.2.7.2 Product Portfolio
5.2.7.3 Target Customers/End Users
5.2.7.4 Analyst View

6. Research Methodology

List of Figures
Figure: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, Market Overview
Figure: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, Epidemiological Analysis, U.S.
Figure: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Coverage
Figure: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Key Trends, Impact Analysis, 2023-2035
Figure: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, Competitive Landscape, January 2022-April 2025

List of Tables
Table: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market, Regulatory Scenario
Table: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Dynamics, Impact Analysis
Table: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Source Type), $Million, 2023-2035
Table: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Target Type), $Million, 2023-2035
Table: Global CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market (by Region), $Million, 2023-2035